Pierre-Edouard de Lamy

CEO & Co-founder at X-PRESSURE

Pierre-Edouard de Lamy is a seasoned professional in finance and business management, currently serving as CEO and Co-founder of X-Pressure since January 2021. In addition to this role, Pierre-Edouard acts as a Private Investor at auum from August 2020. Previously, Pierre-Edouard held the position of COO at Le Grenier à Pain from August 2019 to January 2021, and worked as a Private Equity Associate at RAISE France from June 2018 to August 2019. Early career experience includes a role as an M&A Analyst at Messier Maris & Associés from September 2017 to February 2018. Pierre-Edouard holds a Master's degree in Finance from ESCP Business School and a Bachelor of Laws (LLB) in Business Law & Economics from Université Toulouse 1 Capitole.

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


X-PRESSURE

X-Pressure est un dispositif médical innovant pour la mesure automatique et instantanée de la pression du liquide cérébro-spinal (LCS). La mesure de pression du LCS est historiquement réalisée par l’étude de la colonne d'eau au bout d’une aiguille de ponction lombaire (PL). Cette mesure est longue, imprécise et ne permet pas de détecter d’éventuelles anomalies. Or, une pression anormale peut avoir des conséquences graves pour le cerveau. X-Pressure développe un nouveau dispositif médical simple et précis pour mesurer la pression du LCS au lit du patient. Grâce à un système simple et connecté, le médecin peut mesurer la pression au chevet du patient et poser un diagnostic rapidement grâce à la détection automatique des anomalies utilisant l'intelligence artificielle. Notre mission est de permettre une meilleure prise en charge des maladies liées à une pression intracrânienne anormale ou à un trouble de la circulation du LCS, en particulier l’hydrocéphalie responsable de la perte d'autonomie chez les personnes âgées. --- X-Pressure is an innovative medical device for automatic and instantaneous measurement of crebrospinal fluid (CSF). The measurement of CSF pressure has historically been carried out by studying the water column manometer at the end of a lumbar puncture (LP) needle. This measurement is long, imprecise and unable to detect any anomalies. However, an abnormal CSF pressure can have serious consequences for the brain. X-Pressure is developing a new easy and precise medical device for measuring CSF pressure at the bedside allowing a quick diagnose thanks to an automatic detection system of abnormalities using artificial intelligence. Our mission is to allow better management of diseases where ICP or CSF dynamics are abnormal, in particular hydrocephalus responsible for the loss of autonomy in the elderly.


Headquarters

Toulouse, France

Employees

1-10

Links